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ABSTRACT. Biosignal can provide information about body conditions, including physiological conditions of ischemic stroke. The regulation of blood in the 
brain is regulated through the mechanism of Cerebral Autoregulation (CA). Some parameters that can be used to determine this mechanism are Blood Flow 
Velocity (BFV) and Blood Pressure (BP). Stroke is also related to nervous system activity, which is represented through the Heart Rate Variability (HRV). 
This study aims to determine the relationship between those biosignals and their effects on the physiology of ischemic stroke sufferers. The subjects were 
divided into two groups (20 strokes and 20 controls). BFV data is obtained in the Middle Cerebral Artery (MCA), BP is obtained through the arteries of the 
upper arms, and 3 leads electrocardiogram is placed in the chest. The results showed that there was a relationship between BP and BFV in the control group 
(p-value < 0.05; r = -0.574). This correlation was not found in the stroke group. The relationship between BP and HRV was only found in the stroke group, 
which was associated with high sympathetic activity and lower parasympathetic activity (p-values < 0.05 and r > 0.4). It was based on SDRR, RMSSD, CVRR, 
LF, and SD1 parameters. In the control group, there was no relationship between HRV and BP. The relationship between BFV and HRV in the control group 
was not found statistically. Still, in the stroke group, this relationship was found in the LF and LF/HF Ratio parameters (p-value < 0.05; r > 0.4). Based on this 
research, parameters on HRV that can be used to determine the characteristics of stroke patients in all positions are MeanRR, VLF, and LF.  
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Blood is pumped by the heart to all parts of the body through 
blood vessels. Blood flows have different pressure and 
velocity, depending on where the blood vessels are located. 
In capillaries, blood flows a thousand times slower compare 
to the aorta [1]. 
Abnormal blood pressure causes serious medical 
conditions. Stroke is a disease closely related to excessive 
blood pressure (hypertension). Stroke occurs when blood 
flows into the brain is disrupted, which then damages brain 
cells. The effect of stroke depends on which brain part was 
damaged and also amount of damage it causes. 
The main causes of stroke are ischemic (blockage) and 
hemorrhagic (bleeding). Ischemic strokes are more common 
than hemorrhagic strokes, with a prevalence rate of up to 
85% of total stroke cases [2]. 
Ischemic stroke in elderly patients is a major public 
health problem, as its strong association with many medical 
complications, worse functional outcomes, and large health 
care costs. Compared with young ischemic stroke sufferers, 
elderly ischemic stroke sufferers show more adverse 
outcomes [3]. Young stroke patients also shown better 
neurological and functional recovery after stroke [4] [5]. 
In addition, young stroke patients also make it possible 
to have a better long-term survival rate. A post-stroke study 
of 3864 young stroke patients conducted by [6] found that 
mortality in the young group was 19% lower compared to 
elderly stroke patients. High mortality rates and lower 
outcomes in elderly ischemic stroke sufferers requires 
further study. 
Changes in Heart Rate (HR), both tachycardia (rapid 
heart rate) and bradycardia (slow heart rate) is a 
phenomenon that is often found in acute stroke conditions. 
However, both cannot be used as benchmarks to determine 
the clinical condition in stroke patients [7]. Other parameters 
are needed to explain the condition of stroke patients, so it is 
possible to determine the medical treatment to be performed. 
Post stroke, cerebral autoregulation becomes disturbed 
[8] [9]. Cerebral Autoregulation (CA) is the ability of blood 
vessels to maintain Cerebral Blood Flow (CBF) relatively 
constant to changes in blood pressure through myogenic, 
neurogenic, and complex metabolic mechanisms. CBF 
depends on the condition of blood vessels and arterial blood 
pressure. Blood pressure rises more than 75% in people who 
have an acute stroke [10]. The disruption of CA in stroke 
patients also causes wider atrophy in the brain region, as well 
as reduced functional ability of the body [11]. 
One mechanism that affects CA is the neurogenic 
mechanisms which is associated with the nervous system, 
including the performance of the autonomic nervous system. 
The autonomic nervous system works involuntarily to 
control breathing, digestion, heart rate, blood pressure, and 
others. The nervous system is divided into the sympathetic 
and the parasympathetic nervous system. 
The activity between the sympathetic nervous system 
and parasympathetic can be seen through heart rate 
variability. Heart rate variability (HRV) can quickly indicate 
disruption in the autonomic nervous system [12]. Disruption 
of the balance in the autonomic nervous system certainly 
affects the mechanism in CA. It is therefore important to 
look at HRV as a parameter to determine the balance of the 
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autonomic nervous system associated with CA mechanisms 
in stroke ischemic sufferers. 
This research has hypothesis that the disruption of the 
autonomic nervous system in patients with ischemic stroke 
can be seen through the parameters contained in HRV. Blood 
pressure and blood flow velocity also affects the mechanism 
of CA both in stroke patients and non-stroke. Therefore, an 
understanding of the physiological conditions of elderly 
ischemic stroke patients in terms of blood pressure, blood 
flow velocity, and heart rate variability is needed. 
2. MATERIALS AND METHODS 
2.1 Subjects 
The dataset used in this study is a secondary dataset [13] 
obtained from the Syncope and Falls in the Elderly 
Laboratory and the Magnetic Resonance Imaging Center at 
Beth Israel Deaconess Medical Center (BIDMC) [14]. This 
dataset consists of 40 patients divided into two groups, 20 
patients with stroke and 20 non-strokes (control). The 
subjects of this study are 45-80 years old. 
The stroke group consisted of patients suffering from 
ischemic stroke for 6 months and in a stable clinical 
condition, confirmed by neurological examination with a 
modified Rankin Scale (mRS) < 4, and the National Institute 
Health Stroke Score (NIHSS) < 5 at the time of the study. 
The scale of MRS < 4 and NIHSS < 5 indicate that the 
patient can still respond to two tasks correctly despite a 
decrease in sensory, motoric, and can walk without 
assistance. Patients without a clinical history of stroke 
(control) do not experience a decrease in focus during 
neurological examination. 
Patients who were not included in the study were patients 
with subarachnoid hemorrhage [15], diabetes, arrhythmias 
[16], atrial fibrillation, dementia, obesity with a Body Mass 
Index (BMI) > 35 [17], acute medical conditions, alcohol 
and drug abuse, and severe hypertension (systole > 200 
diastole > 110 or patients with 3 or more anti-hypertension) 
[18]. 
2.3 Experimental Design  
Subjects were taken by sitting, standing, supine (baseline), 
and tilted positions. BP is recorded using Dynamap placed 
on the upper arm and BFV is recorded using Transcranial 
Doppler (TCD) placed on the right and left Middle Cerebral 
Artery (MCA). 
ECG data is retrieved using the ME6000 
(MegaElectronics) 12 leads device. Records during the 
baseline and tilt positions are taken for 10 minutes. Sit-stand 
position is taken with the protocol for 5 minutes sitting with 
eyes open (SitEO), 5 minutes standing in the open eyes 
(StandEO), then 5 minutes sitting with eyes closed (SitEC) 
and 5 minutes standing in a closed eyes (StandEC). Each 
position is taken with a 1000 Hz sampling rate. 
2.4 Signal Processing and Features Extraction 
ECG data is processed using Python 3.7 signal 
processing tools to get the R Peak in the stroke and control 
groups. The R-peak on the ECG signal in each subject is 
detected using the Two-Moving Average Method. Detection 
results for each R-Peak are accommodated simultaneously 
with the position of the x-axis. The detected R-Peak position 
is then used to calculate the distance between the R-Peak (R-
R interval). 
The R-R interval is obtained by calculating the difference 
in the position of the R-Peak with the R-Peak position 
afterwards. After getting the R-R interval, new time series 
data is obtained. This time series data is then used for HRV 
parameter analysis. 
HRV parameters in the time domain include: MeanRR, 
SDRR, RMSSD, and CVRR. In the Poincaré Plot, the 
parameters used are SD1 and SD2. Analysis of the frequency 
domain begins with transforming time series data into the 
form of frequency functions using the pyhrv package in 
python. This step starts by checking the value of the R-R 
interval, then interpolating with a sampling frequency of 4 
Hz. The interpolation signal is then computed by Power 
Spectral Density (PSD) and its parameters (VLF, LF, HF, 
and LF/HF ratio).  
2.5 Data Analysis 
The data in this study are not normally distributed, so the 
average test (significance test) is using non-parametric tests. 
The Mann-Whitney U Method is a non-parametric test that 
can provide the most accurate averaging estimate, when the 
sample size is small, and the data are not normally 
distributed [19]. This method can be used to provide 
significant values on Waist-Hip Ratio (WHR), Body Mass 
Index (BMI), and HRV data between the obese and normal 
groups with a sample size < 30 in each group [20]. Because 
the data of this study are not normally distributed and the 
sample data is < 30 in each group, the significance test in this 
study uses the Mann-Whitney U Method. 
Spearman Rank Correlation Test was conducted to 
determine the relationship between BP parameters, BFV, 
and HRV in each group. Data are presented using mean ± 
standard deviations (Mean ± SD). The significant value (p-
value) used in this study is 0.05. The magnitude of the 
correlation is expressed in the coefficient correlation (r). All 




Descriptive statistics are used to summarize all variables in 
the subject demographics. Table 1 shows a demographic 
summary of each groups. There was no difference in age and 
systolic blood pressure between the stroke and control 
groups (p-value > 0.05). Likewise, with the right and left 
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MCA diameters, smoking history, and alcohol history. In 
demographics of body mass index and diastolic blood 
pressure, the mean in the stroke group tended to be higher 
than in the control group. Regarding differences in body 
mass index and diastolic blood pressure in the two groups 
will be discussed in the discussion section 
3.2 Blood Pressure 
Blood Pressure’s significance test for the stroke and control 
groups are shown in Table 2. Based on these results, BP in 
each position has a p-value > 0.05. This means that there is 
no significant difference in BP average between the two 
groups. Mean BP was shown as Mean Arterial Pressure 
(MAP). 
Although there is no significant difference between the 
stroke and control groups, the BP average in the stroke group 
is always higher than the control group. The BP average in 
the stroke group increased by 3-7 mmHg (Fig. 1). In 
addition, the average BP in both groups also increased when 
there was a change in position from the baseline. 
3.3 Blood Flow Velocity 
Blood Flow Velocity results between stroke group and the 
control group showed no significant difference. Table 3 
shows the results of the BFV significance test, where there was no significant difference between the stroke and control 
groups. 
 
The mean BFV in the stroke group was lower than the 
control group (Fig. 2) in any positions. If the average BP has 
increased when there is a change in position, this applies in 
reverse to the BFV. 
3.4 Heart Rate Variability  
HRV analysis is performed in time domain, frequency 





(Mean ± SD) 
Control 
(Mean ± SD) 
p-value 
Age 64 ± 10.11 67 ± 7.53 0.273 
Gender (M/F) 7/13 9/11 0.524 
Body Mass Index (kg/m) 28.34 ± 3.83 25.15 ± 4.57 0.012* 
SBP (mmHg) 135.62 ± 8.58 130.43 ± 11.85 0.168 
DBP (mmHg) 69.42 ± 5.84 63.48 ± 5.75 0.003* 
Right MCA Diameter 2.13 ± 0.64 2.38 ± 0.23 0.240 
Left MCA Diameter 2.48 ± 0.28 2.43 ± 0.22 0.762 
Smoking History (Y/N) 13/7 7/13 0.061 
Alcohol History (Y/N) 15/5 16/4 0.708 
NIHSS 3 ± 2.28 - - 
mRS 1 ± 1.08 - - 
Stroke Side (Right/Left) 8/12 - - 
 
* Significant level 0.05 
SD=Standard Deviation, M=Male, F=Female, SBP=Systolic Blood Pressure, 
DBP=Diastolic Blood Pressure, MCA=Middle Cerebral Artery, Y=Yes, N=No, 
NIHSS=National Institute Health Stroke Score, mRS=modified Rankin Score. 
TABLE 2 
BLOOD PRESSURE SIGNIFICANCE TEST 
Position 
Control 
(Mean ± SD) 
Stroke 
(Mean ± SD) 
p-value 
Baseline 79.99 ± 9.90 83.78 ± 9.27 0.219 
Tilt 82.61 ± 12.63 88.23 ± 9.82 0.128 
Sit Eyes Open 87.14 ± 12.44 90.14 ± 6.69 0.372 
Stand Eyes Open 87.52 ± 12.98 93.18 ± 7.80 0.120 
Sit Eyes Close 90.08 ± 13.15 93.57 ± 10.62 0.392 
Stand Eyes Close 90.45 ± 15.52 97.06 ± 13.03 0.186 
 
TABLE 3 
BLOOD FLOW VELOCITY SIGNIFICANCE TEST 
Position 
Control 
(Mean ± SD) 
Stroke 
(Mean ± SD) 
p-value 
Baseline 46.37 ± 16.15 40.99 ± 23.94 0.226 
Tilt 42.97 ± 14.17 40.22 ± 22.24 0.389 
Sit Eyes Open 41.54 ± 12.48 37.98 ± 16.71 0.352 
Stand Eyes Open 40.29 ± 14.04 36.95 ± 17.08 0.270 
Sit Eyes Close 39.51 ± 12.27 35.20 ± 16.51 0.168 
Stand Eyes Close 36.81 ± 12.15 34.27 ± 17.70 0.368 
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to find out the differences in HRV in the stroke and control 
groups. 
HRV parameters used in the time domain are MeanRR, 
SDRR, RMSSD, and CVRR. Significance test shows that 
each HRV parameter in the two groups gave different 
significant results (Table 4). Almost all p-values in the 
MeanRR parameter are smaller than 0.05 for each position, 
except for the StandEC position (p-value> 0.5). This means 
that commonly there are significant differences between the 
stroke and control groups in the MeanRR parameters. 
In the SDRR parameters, significant differences in stroke 
and control groups were only seen at the baseline and 
StandEO positions (p-value <0.05). Apart from these two 
positions, the SDRR parameter did not show a significant 
difference (p-value> 0.5) among the two groups. 
The RMSSD parameters in the significance test did not 
show a significant difference between the stroke and control 
groups in all positions (p-value> 0.05). This means that the 
mean RMSSD in the two groups is the same. The CVRR 
parameter only shows a significant difference in the baseline 
position (p-value <0.05). 
Significance tests were carried out on both groups, to 
determine the difference in the frequency domain in each 
parameter/powerband. The results of the significance tests 
are shown in Table 5. In the VLF parameter a significant 
difference is shown in the baseline position and stand eyes 
open (p-value < 0.05). Other parameters that showed 
significant differences between the two groups were the LF 
parameter at the baseline position and sit eyes open, and the 
HF parameter at the baseline position. The LF/HF Ratio did 
not show any significant difference between the two groups. 
Generally, through the significance test, more significant 
differences in various positions are shown in the VLF and 
LF parameters. However, the stroke group with the control 
group at the baseline position showed the most significant 
difference in all power bands. 
To find out the differences in HRV through non-linear 
analysis (Poincaré Plot) between the stroke group and the 
control group, a significance test was performed on the 
parameters SD1 and SD2. Poincaré Plot significance test 
results for each parameter in various positions as shown in 
Table 6.  
TABLE 4 
HEART RATE VARIABILITY (FREQUENCY DOMAIN) SIGNIFICANCE TEST 
Position 
Control 
(Mean ± SD) 
Stroke 
(Mean ± SD) 
p-value 
VLF Base 344.93 ± 188.97 165.68 ± 140.76 0.002* 
VLF Tilt 134.16 ± 151.54 102.47 ± 120.84 0.607 
VLF SitEO 505.11 ± 680.32 234.93 ± 130.21 0.117 
VLF StandEO 503.16 ± 346.10 268.88 ± 294.29 0.009* 
VLF SitEC 507.23 ± 576.16 454.32 ± 328.32 0.978 
VLF StandEC 262.50 ± 196.69 198.40 ± 118.31 0.516 
LF Base 206.64 ± 87.14 103.37 ± 74.77 < 0.001** 
LF Tilt 112.20 ± 214.38 82.89 ± 179.50 0.745 
LF SitEO 422.04 ± 691.69 133.36 ± 103.89 0.006* 
LF StandEO 362.21 ± 638.60 211.01 ± 476.07 0.144 
LF SitEC 321.55 ± 349.06 314.35 ± 480.79 0.344 
LF StandEC 226.28 ± 320.78 129.92 ± 127.05 0.766 
HF Base 152.69 ± 146.62 59.41 ± 52.96 0.009* 
HF Tilt 48.02 ± 85.42 78.93 ± 255.15 0.160 
HF SitEO 391.79 ± 661.78 234.32 ± 290.56 0.935 
HF StandEO 395.14 ± 919.35 238.39 ± 691.09 0.808 
HF SitEC 441.30 ± 691.82 378.90 ± 659.30 0.372 
HF StandEC 561.27 ± 1812.36 149.35 ± 221.66 0.871 
LF/HF Base 2.292 ± 2.073 2.216 ± 1.260 0.552 
LF/HF Tilt 2.589 ± 3.355 2.773 ± 2.659 0.646 
LF/HF SitEO 2.887 ± 3.211 1.076 ± 0.788 0.105 
LF/HF StandEO 4.262 ± 5.982 1.725 ± 1.211 0.402 
LF/HF SitEC 2.241 ± 2.942 1.622 ± 1.551 0.978 
LF/HF StandEC 2.902 ± 4.400 1.719 ± 2.333 0.935 
 
TABLE 6 
HEART RATE VARIABILITY (POINCARÉ PLOT) SIGNIFICANCE TEST 
Position 
Control 
(Mean ± SD) 
Stroke 
(Mean ± SD) 
p-value 
SD1 Base 17.58 ± 11.40 11.36 ± 7.72 0.094 
SD1 Tilt 9.52 ± 8.17 8.50 ± 7.67 0.745 
SD1 SitEO 21.56 ± 19.52 19.36 ± 14.69 0.850 
SD1 StandEO 17.85 ± 17.75 13.70 ± 14.55 0.787 
SD1 SitEC 24.05 ± 19.77 19.48 ± 14.55 0.344 
SD1 StandEC 21.67 ± 26.17 16.84 ± 15.92 0.914 
SD2 Base 47.60 ± 14.57 30.29 ± 11.81 < 0.001** 
SD2 Tilt 23.26 ± 8.25 19.88 ± 7.19 0.245 
SD2 SitEO 45.35 ± 20.94 35.61 ± 9.45 0.088 
SD2 StandEO 40.33 ± 13.09 30.01 ± 13.73 0.006* 
SD2 SitEC 44.96 ± 15.76 43.08 ± 18.33 0.516 
SD2 StandEC 38.57 ± 18.12 30.67 ± 9.59 0.279 
 
TABLE 5 
HEART RATE VARIABILITY (TIME DOMAIN) SIGNIFICANCE TEST 
Position 
Control 
(Mean ± SD) 
Stroke 
(Mean ± SD) 
p-value 
MeanRR Base 484.69 ± 67.56 429.83 ± 39.61 0.003* 
MeanRR Tilt 428.63 ± 70.57 378.00 ± 38.59 0.025* 
MeanRR SitEO 944.11 ± 160.67 842.95 ± 69.15 0.027* 
MeanRR StandEO 844.85 ± 152.74 744.28 ± 84.10 0.042* 
MeanRR SitEC 954.42 ± 165.74 832.74 ± 75.76 0.007* 
MeanRR StandEC 831.46 ± 164.47 731.48 ± 88.70 0.079 
SDRR Base 36.34 ± 11.68 23.32 ± 8.83 < 0.001** 
SDRR Tilt 18.26 ± 7.00 15.62 ± 6.69 0.279 
SDRR SitEO 36.30 ± 18.70 29.45 ± 10.21 0.204 
SDRR StandEO 32.15 ± 13.39 23.80 ± 13.30 0.009* 
SDRR SitEC 37.10 ± 15.45 34.10 ± 15.04 0.433 
SDRR StandEC 32.66 ± 20.35 25.49 ± 11.54 0.267 
RMSSD Base 24.86 ± 16.12 16.06 ± 10.92 0.094 
RMSSD Tilt 13.46 ± 11.54 12.02 ± 10.84 0.745 
RMSSD SitEO 30.44 ± 27.55 27.34 ± 20.74 0.850 
RMSSD StandEO 25.18 ± 25.04 19.34 ± 20.54 0.787 
RMSSD SitEC 33.95 ± 27.91 27.51 ± 20.55 0.344 
RMSSD StandEC 30.56 ± 36.91 23.76 ± 22.46 0.914 
CVRR Base 0.074 ± 0.020 0.054 ± 0.019 0.002* 
CVRR Tilt 0.043 ± 0.016 0.041 ± 0.018 0.589 
CVRR SitEO 0.038 ± 0.017 0.035 ± 0.013 0.797 
CVRR StandEO 0.038 ± 0.017 0.032 ± 0.018 0.076 
CVRR SitEC 0.039 ± 0.017 0.041 ± 0.018 0.766 
CVRR StandEC 0.040 ± 0.025 0.035 ± 0.016 0.636 
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There was no significant difference in the SD1 parameter 
(p-value > 0.05) in all positions. Different results are shown 
in SD2 parameters which indicate that there are significant 
differences between the two groups. This condition is found 
only in the baseline and StandEO positions 
 
3.5 Blood Pressure and Blood Flow Velocity  
The Spearman Correlation Rank Test was used to determine 
the relationship between BP and BFV in both groups. The 
correlation test results in Table 7 show that in the control 
group, a relationship was found between BP and BFV at the 
SitEC position (p-value <0.05). The correlation shown is a 
negative correlation with a correlation coefficient of 0.574, 
which means that there is a strong correlation between BP 
and BFV in the control group. Different results are shown in 
the stroke group. In the stroke group, there was no 
relationship between BP and BFV in various positions with 
a p-value > 0.05. 
3.6 Blood Pressure and Heart Rate Variability 
The association between BP and HRV was also tested using 
the same method as the BP test with BFV. Correlation test 
results between BP and time domain HRV in the control 
group are shown in Table 8. As seen in the table, the results 
of the correlation test between BP and HRV time domains in 
all positions in the control group have p-value > 0.05. This 
means that the control group did not show any relationship 
between BP and HRV in the time domain. Each HRV 
parameter in the frequency domain (VLF, LF, HF, and 
LF/HF Ratio) did not have any correlation with BP in the 
control group (p-value> 0.05). HRV on the Poincaré Plot is 
shown with parameters SD1 and SD2. In the control group, 
no relationship was found between BP and the two 
parameters in all positions. The significance value indicated 
more than 0.05 (p-value > 0.05).  
Correlation test in the stroke group gives different results 
in several positions (Table 9). Baseline, tilt, sit eyes open, 
and stand eyes open positions do not indicate a relationship. 
However, in sit eyes close and stand eyes close position, the 
parameters SDRR, RMSSD, and CVRR have a correlation 
with BP (p-value <0.05). The direction of the positive 
correlation is indicated between these parameters with BP, 
with a strong correlation level (r > 0.5). Correlation test 
between BP and HRV frequency domain showed an 
association (Table 9). The correlation coefficient (r) on the 
TABLE 7 
BP VS BFV CORRELATION 
Position 
Control Group Stroke Group 
SBP DBP SBP DBP 
Baseline 
r -0.388 -0.100 -0.039 0.254 
p-value 0.101 0.684 0.875 0.293 
Tilt 
r 0.049 0.019 -0.274 0.047 
p-value 0.842 0.937 0.257 0.847 
SitEO 
r -0.485 -0.288 0.296 -0.042 
p-value 0.057 0.279 0.233 0.868 
StandEO 
r -0.218 -0.147 0.323 -0.071 
p-value 0.418 0.587 0.191 0.779 
SitEC 
r -0.574 -0.465 0.176 -0.03 
p-value 0.020* 0.070 0.484 0.906 
StandEC 
r -0.212 -0.247 0.301 0.238 
p-value 0.431 0.356 0.240 0.358 
* p-value < 0.05, SBP=Systolic Blood Pressure, DBP=Diastolic Blood 
Pressure, r=Coefficient Correlation, p-value=Significance Level 
 
TABLE 8 
BP VS HRV CORRELATION CONTROL GROUP 
Blood Pressure 
Baseline Tilt SitEO StandEO SitEC StandEC 
SDP DBP SDP DBP SDP DBP SDP DBP SDP DBP SDP DBP 
MeanRR 
r -0.021 -0.108 0.381 0.042 0.168 -0.2 0.326 -0.218 0.271 -0.291 0.282 -0.247 
p-value 0.93 0.65 0.108 0.864 0.535 0.458 0.217 0.418 0.311 0.274 0.289 0.356 
SDRR 
r 0.238 -0.023 -0.032 0.033 -0.115 -0.209 0.097 -0.026 0.218 -0.018 -0.147 -0.212 
p-value 0.313 0.925 0.898 0.892 0.672 0.438 0.721 0.922 0.418 0.948 0.587 0.431 
RMSSD 
r 0.311 -0.017 0.298 0.14 0.238 -0.171 0.126 -0.194 0.324 -0.185 0.147 -0.094 
p-value 0.182 0.945 0.215 0.567 0.374 0.528 0.641 0.471 0.222 0.492 0.587 0.729 
CVRR 
r 0.324 0.06 -0.135 0.093 -0.2 -0.229 0.038 0.085 0.135 0.112 -0.291 -0.197 
p-value 0.163 0.801 0.581 0.705 0.458 0.393 0.888 0.753 0.617 0.68 0.274 0.464 
VLF 
r -0.006 -0.269 -0.175 -0.047 -0.244 -0.268 0.224 -0.118 0.335 0.074 -0.029 -0.003 
p-value 0.98 0.251 0.473 0.847 0.362 0.316 0.405 0.664 0.204 0.787 0.914 0.991 
LF 
r 0.146 -0.074 -0.421 -0.237 -0.115 -0.062 0.182 0.05 0.071 0.032 0.156 0.021 
p-value 0.539 0.758 0.073 0.329 0.672 0.82 0.499 0.854 0.795 0.905 0.564 0.94 
HF 
r 0.325 -0.027 -0.295 0.021 0.185 -0.268 0.168 -0.235 0.312 -0.262 0.332 -0.044 
p-value 0.162 0.91 0.221 0.932 0.492 0.316 0.535 0.38 0.24 0.327 0.208 0.871 
LF/HF Ratio 
r -0.26 -0.12 -0.151 -0.298 -0.362 0.162 -0.25 0.226 -0.197 0.406 -0.422 0.128 
p-value 0.268 0.613 0.538 0.215 0.169 0.549 0.35 0.399 0.464 0.119 0.103 0.637 
SD1 
r 0.311 -0.017 0.298 0.14 0.238 -0.171 0.126 -0.194 0.324 -0.185 0.147 -0.094 
p-value 0.182 0.945 0.215 0.567 0.374 0.528 0.641 0.471 0.222 0.492 0.587 0.729 
SD2 
r 0.167 -0.045 -0.132 0.005 -0.247 -0.268 0.047 -0.029 0.065 -0.035 -0.079 -0.115 
p-value 0.482 0.85 0.591 0.983 0.356 0.316 0.863 0.914 0.812 0.897 0.77 0.672 
* p-value < 0.05, SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure, r=Coefficient Correlation, p-value=Significance Level 
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LF parameter shows a positive number and more than 0.5 
indicates that there is a strong direct relationship between the 
LF parameter and BP. The correlation between BP and HRV 
Poincaré Plot was found in the stroke group, with the p-value 
and correlation coefficient on the SD1 parameter (0.02 ± 
0.542) in the StandEC position. It was shown positive 
correlation between BP and SD1, which means that both of 
them have a direct association.  
Based on several correlation tests that have been 
conducted between BP and HRV, the correlation is only 
TABLE 10 
BP VS HRV CORRELATION STROKE GROUP 
Blood Pressure 
Baseline Tilt SitEO StandEO SitEC StandEC 
SDP DBP SDP DBP SDP DBP SDP DBP SDP DBP SDP DBP 
MeanRR 
r -0.259 -0.093 0.256 0 -0.154 0.096 -0.065 0.065 0.214 0.081 0.381 0.201 
p-value 0.271 0.696 0.277 1 0.528 0.694 0.792 0.792 0.379 0.743 0.119 0.423 
SDRR 
r -0.242 -0.024 0.065 -0.168 0.281 0.293 0.081 0.005 0.481 0.16 0.616 0.143 
p-value 0.304 0.92 0.787 0.478 0.244 0.223 0.743 0.983 0.037* 0.514 0.006* 0.57 
RMSSD 
r 0.122 -0.164 0.198 -0.229 0.219 0.074 0.016 0.161 0.4 -0.03 0.542 0.088 
p-value 0.609 0.49 0.402 0.332 0.367 0.764 0.949 0.509 0.09 0.904 0.020* 0.729 
CVRR 
r -0.173 0.036 0.026 -0.119 0.268 0.344 0.126 0.144 0.461 0.158 0.531 0.132 
p-value 0.466 0.88 0.915 0.618 0.267 0.149 0.606 0.557 0.047* 0.519 0.023* 0.601 
VLF 
r -0.232 -0.074 -0.032 -0.179 0.2 0.419 0.096 -0.044 0.305 0.393 0.259 -0.146 
p-value 0.326 0.758 0.895 0.45 0.412 0.074 0.694 0.858 0.204 0.096 0.299 0.565 
LF 
r -0.275 0.008 -0.179 -0.338 0.246 0.56 0.005 -0.346 0.274 0.111 0.214 0.055 
p-value 0.24 0.975 0.45 0.145 0.311 0.013* 0.983 0.147 0.257 0.652 0.395 0.829 
HF 
r -0.269 -0.104 -0.438 -0.385 0.2 0.139 -0.079 -0.232 0.309 -0.077 0.391 0.104 
p-value 0.251 0.663 0.054 0.094 0.412 0.571 0.748 0.34 0.198 0.753 0.108 0.681 
LF/HF Ratio 
r -0.002 0.041 0.427 0.183 -0.133 0.1 0.107 0.002 -0.074 0.142 -0.259 0.02 
p-value 0.995 0.865 0.06 0.439 0.586 0.684 0.663 0.994 0.764 0.562 0.299 0.938 
SD1 
r 0.122 -0.164 0.198 -0.229 0.219 0.074 0.016 0.161 0.4 -0.03 0.542 0.088 
p-value 0.609 0.49 0.402 0.332 0.367 0.764 0.949 0.509 0.09 0.904 0.020* 0.729 
SD2 
r -0.352 -0.009 -0.086 -0.232 0.344 0.346 0.044 0.025 0.377 0.109 0.467 0.102 
p-value 0.128 0.97 0.719 0.326 0.149 0.147 0.858 0.92 0.111 0.658 0.05 0.687 
* p-value < 0.05, SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure, r=Coefficient Correlation, p-value=Significance Level 
 
TABLE 9 
BFV VS HRV CORRELATION 
Blood Flow 
Velocity 
Control Group Stroke Group 













r 0.146 0.344 -0.012 0.029 -0.024 0.009 -0.107 -0.033 0.135 0.119 0.181 0.284 
p-value 0.552 0.149 0.966 0.914 0.931 0.974 0.663 0.892 0.593 0.639 0.473 0.269 
SDRR 
r -0.095 0.181 0.185 0.382 -0.194 0.15 0.098 0.225 0.098 0.255 0.013 0.235 
p-value 0.7 0.459 0.492 0.144 0.471 0.579 0.689 0.355 0.699 0.307 0.958 0.363 
RMSSD 
r -0.025 0.253 0.265 0.232 -0.035 0.021 0.037 0.233 0.02 0.255 -0.044 0.275 
p-value 0.92 0.297 0.322 0.387 0.897 0.94 0.881 0.336 0.938 0.307 0.861 0.286 
CVRR 
r -0.295 0.035 0.347 0.456 -0.144 0.138 0.189 0.267 0.129 0.115 0.018 0.074 
p-value 0.22 0.887 0.188 0.076 0.594 0.61 0.437 0.27 0.61 0.651 0.945 0.779 
VLF 
r -0.219 0.247 0.182 0.479 -0.344 0.212 -0.032 0.382 0.307 0.094 0.055 0.414 
p-value 0.367 0.307 0.499 0.06 0.192 0.431 0.898 0.106 0.216 0.711 0.829 0.098 
LF 
r -0.016 0.033 0.065 0.2 -0.024 0.291 -0.037 0.461 0.245 0.317 0.16 0.14 
p-value 0.949 0.892 0.812 0.458 0.931 0.274 0.881 0.047* 0.328 0.2 0.526 0.593 
HF 
r -0.196 -0.053 0.259 0.171 0.088 0.082 0.384 0.302 0.03 0.249 0.015 0.377 
p-value 0.42 0.831 0.333 0.528 0.745 0.762 0.104 0.209 0.906 0.32 0.951 0.135 
LF/HF 
Ratio 
r 0.258 0.193 -0.191 0.015 -0.068 0.007 -0.496 -0.221 0.16 -0.061 0.183 -0.135 
p-value 0.286 0.429 0.478 0.957 0.803 0.978 0.031* 0.363 0.526 0.81 0.468 0.606 
SD1 
r -0.025 0.253 0.265 0.232 -0.035 0.021 0.037 0.233 0.02 0.255 -0.044 0.275 
p-value 0.92 0.297 0.322 0.387 0.897 0.94 0.881 0.336 0.938 0.307 0.861 0.286 
SD2 
r -0.116 0.074 0.156 0.371 -0.174 0.138 0.054 0.26 0.3 0.152 0.022 -0.044 
p-value 0.637 0.764 0.564 0.158 0.52 0.61 0.825 0.283 0.226 0.548 0.932 0.866 
* p-value < 0.05, SBP=Systolic Blood Pressure, DBP=Diastolic Blood Pressure, r=Coefficient Correlation, p-value=Significance Level 
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shown in the stroke group. A strong correlation is seen in the 
parameters SDRR, RMSSD, CVRR, LF, and SD1. The 
control group did not show any relationship between BP and 
HRV. 
3.7 Blood Flow Velocity and Heart Rate Variability  
The results of the BFV-HRV correlation test in the control 
group are shown in Table 10. The results in the table show 
the p-value > 0.05 in all positions. This means that none of 
the HRV parameters in the group indicate a relationship with 
BFV. 
Different results are shown in the stroke group. 
Correlation tests conducted in the stroke group showed a 
relationship between BFV and HRV in several positions. 
Heart Rate Variability parameters that indicate a 
relationship with BFV are only found in the frequency 
domain HRV (p-value < 0.05). HRV parameters in the 
frequency domain that show a relationship between HRV 
and BFV are LF parameters and LF/HF Ratio. This 
relationship is only shown in the baseline and tilt positions 
 
4.   DISCUSSIONS 
This study compared Blood Pressure (BP), Blood Flow 
Velocity (BFV), and Heart Rate Variability (HRV) between 
control group and stroke group. The results of this study 
indicate that BP in the stroke group is higher than the control 
group in all positions. Hypertension is still become the most 
common risk factors in stroke patients [21] [22]. Other 
stroke mechanisms related to hypertension caused by mental 
stress [23] and increased sympathetic activity [24]. 
Changes in position also affect the results of BP 
measurement. BP was seen increasing between the two 
groups, as positions changed. At the baseline position, BP 
shows lower result than when sitting position [25]. Although 
BP in the stroke group was higher, it does not mean that 
stroke has caused BP increasing. In some cases, 
hypertension which then becomes a risk factor for stroke 
[26]. But one thing that is certain is that the average BP in 
the stroke group was indeed higher compared to the control 
group. 
Blood Flow Velocity among right and left sides in stroke 
and control group has confirmed there is no significant 
difference in all positions. Although it was not showing a 
significant difference between the two groups, BFV in stroke 
group was slower than the control group in all positions. 
Blood Flow Velocity is influenced by blood vessel diameter, 
blood vessel elasticity, blood viscosity, and strength of heart 
muscle contraction. [1]  
Deceleration BFV in the stroke group is possible due to 
blood viscosity. Blood viscosity has an influence on blood 
pressure [27]. Systolic blood pressure, diastole, and Mean 
Arterial Pressure (MAP) increase with increasing blood 
vascularity. In the subject demographics, there was no 
significant difference in the systole between the two groups. 
However, the mean diastole in the stroke group was 
significantly higher than the control group. Because blood 
pressure is influenced by systole and diastole, the high 
diastole value certainly increases MAP value. In addition, 
the increase in MAP is also due to the high viscosity. High 
viscosity influences slower blood flow in the blood vessels 
to the brain. The slowing down of BFV is then a risk factor 
for stroke [28]. 
Subject demographics showed significant differences 
between the control group and the stroke group on Body 
Mass Index (BMI). Nonetheless, research [20] [29] shows 
that BMI does not affect heart rate variability in obese 
subjects (p-value > 0.05). Considering obesity is a risk factor 
for stroke, it can be concluded that the value of each HRV 
parameter is not absolutely caused by differences in BMI. 
In common, HRV in the stroke group was lower than in 
the control group. Some similar medical conditions are also 
found in certain diseases. Elderly hypertensive patients have 
decreased heart rate variability [30]. Significant decreases in 
HRV are also found in people with psychiatric disorders 
such as schizophrenia [31] and bipolar disorder [32]. 
The decrease in HRV in the stroke group indicates that 
there is interference in the autonomic nervous system. The 
lower variability in the stroke group is made possible by 
obstruction of the hemisphere and medullary rods which 
then damage the autonomic system, resulting abnormalities 
in the HRV characteristics [33]. The decrease in 
parasympathetic activity in the stroke group is shown by the 
low value of the RMSSD and SD1 parameters. Although the 
RMSSD and SD1 parameters between the two groups in this 
study did not show any significant differences in various 
positions, the differences were significantly seen through the 
HF parameters at the baseline position. 
Previous studies have shown that RMSSD is associated 
with HF in men during sleep [34]. The relationship between 
the two parameters shows indirectly differences in 
parasympathetic system activity between the stroke group 
and the control group. It can be seen in the baseline position 
through the HF parameter. During breathing, the 
cardiorespiratory center blocks the flow of vagal outflow, 
causing the heart beating faster [35]. A faster heart rate 
indicates a high frequency (HF) in the frequency domain. 
Sympathetic and parasympathetic nervous system 
activities contribute to the SDRR parameters [36]. Research 
conducted by [8] found that low SDNN in patients with 
sepsis can be an important predictor related to patient 
mortality in hospitals with a prediction rate of 70%. In 
general, SDRR parameters in the control group were higher 
than the stroke group. These conditions indicate that the 
autonomic nervous system in the control group is much 
better. Significant differences in the SDRR parameters can 
only be seen in the baseline and StandEO positions. 
Disregulation of the control of the autonomic nervous 
system is associated with high sympathetic nerves and 
decreased parasympathetic nerves [37]. 
RMSSD parameters as a representation of 
parasympathetic activity showed no significant differences 
in the two groups. SDRR which is a representation of the 
sympathetic and parasympathetic nervous system, showed a 
significant difference between the stroke group and the 
control group. If the parasympathetic nervous system does 
not show any difference, then a significant difference in the 
SDRR must be due to sympathetic nervous system activity.  
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Several studies have shown an association between 
SDRR parameters with LF and VLF parameters [38] [39] 
[40]. The same result is shown by the significant difference 
between the SDRR parameters and the LF parameters at the 
baseline position, and the SDRR parameters with VLF at the 
StandEO position. Other studies [41] [42] [43] also 
mentioned that the high activity of the sympathetic nervous 
system in the frequency domain is reflected through the low 
LF parameters. Similar results were also found in [44], 
which showed that the mean LF in 329 fibromyalgia patients 
(388.99 Hz) was significantly lower compared to 58 normal 
patients (470.0 Hz). 
The control group had higher mean VLF and LF than the 
stroke group. The average VLF and LF in the control group 
were 344.93 s2/Hz and 206.64 s2/Hz, whereas in the stroke 
group were 165.68 s2/Hz and 103.37 s2/Hz. Under normal 
conditions, healthy subjects do show an increase in VLF at 
rest [45]. The same condition was also shown in this study, 
where the stroke group had a lower mean VLF and LF 
compared to the control group. This means that there is a 
parasympathetic nervous system disorder, which in this case 
is characterized by high sympathetic activity in the stroke 
group. Low VLF at resting conditions is associated with 
increased chronic inflammation [46] and death from 
arrhythmias [47]. Excessive sympathetic nerve activity is 
also shown in people with hypertension [48]. Several factors 
cause high sympathetic activity, including genetic factors, 
stress, obesity, and absence of physical activity [49]. In 
people with stroke, these factors can then increase 
sympathetic nerve activity. 
Autonomic nervous system activity can also be seen 
through the parameters SD1 and SD2 found in non-linear 
analysis using Poincaré Plot. SD1 (short-term variability) 
parameters related to parasympathetic nervous system 
activity in the stroke group showed a lower mean. As 
explained earlier, although the stroke group had a lower 
SD1, no significant difference was found between the two 
groups. The parameter SD2 (long-term variability) in the 
Poincaré Plot shows more activity from the sympathetic 
nervous system. The lower SD2 parameter indicates that the 
sympathetic nervous system activity is getting higher [50] 
[51]. The stroke group had a lower SD2 value compared to 
the control group. The most significant difference was seen 
in the baseline and StandEO positions. This is consistent 
with the results of the analysis using a linear method, that 
increased sympathetic nervous system activity is also seen 
through Poincaré Plot analysis on SD2 parameters. The 
results of this study at the same time confirm previous 
studies [52], that ischemic stroke is largely characterized by 
the dominance of sympathetic nervous system activity. 
Total function of the autonomic nervous system is shown 
by using the CVRR parameter, while the change in 
autonomic nerve activity from sympathetic to 
parasympathetic is indicated through the LF/HF Ratio. The 
CVRR parameter in the stroke group lower than the control 
group. Significant differences between the two groups were 
only shown in the baseline position. Thus, the total function 
of the autonomic nervous system in the control group is 
better than the stroke group, especially seen at the baseline 
position. Significant differences between the two groups 
were not seen in changes in autonomic nerve activity from 
sympathetic to parasympathetic, which in this case was 
represented through the LF/HF Ratio. Similar results were 
also found in studies [53] [54]. 
Regarding BP and BFV in the control and stroke group, 
the results of this study showed that in the control group, 
there was a strong relationship at the SitEC position. The 
negative correlation between BP and BFV in the control 
group shows that the higher BP, will be followed by lower 
BFV. The mechanism of CA in healthy subjects involves 
rapid adjustment of brain blood vessels, so that BFV remains 
stable in response to changes in BP [8]. In the stroke group, 
there was no relationship between BP and BFV. Thus, BP 
and BFV, which affect the CA mechanism, have indeed been 
reduced after a stroke [8] [9]. 
In the control group no relationship was found between 
BP and HRV in all domains. Changes in position and 
physical activity do allow changes in HRV, but do not have 
a significant effect on BP [55]. Different results were found 
in the stroke group. A significant relationship was found 
between BP and HRV (SDRR, RMSSD, CVRR, LF, SD1). 
Sympathetic activation contributes to increasing blood 
pressure in hypertensive patients. This is what then causes 
high blood pressure in the stroke group. The positive 
correlation between HRV and BP in the stroke group 
indicates that higher sympathetic nerve activity, causing BP 
to increase. 
There was no relationship between BFV and HRV in the 
control group, whereas in the stroke group this relationship 
was seen in the LF parameter and the LF/HF Ratio. BFV in 
the MCA will increase according to increasing heartbeat 
[56]. Improving the heartbeat is a form of sympathetic 
nervous system. A positive correlation between sympathetic 
nerve (LF) and BFV is also shown in stroke patients. Stroke 
sufferers who are more dominated by sympathetic nerve 
activity show an increase in the speed of blood flow to meet 
the blood supply to the brain. This also confirms the research 
[57], that the CA mechanism related to BFV in MCA can 
operate efficiently in the LF range rather than the HF range. 
The correlation shown between BFV and HRV in this 
study is not strong enough to show the overall CA 
mechanism. The CA mechanism in stroke patients which is 
very complex and involves many other regulations (such as 
myogenic, neurogenic, metabolic, etc.) need a further 
research. 
5.   CONCLUSION 
Blood pressure (BP) in the ischemic stroke group with some 
exclusions in this study was higher than in the control group, 
whereas Blood Flow Velocity (BFV) in the ischemic stroke 
group was faster than the control group. Almost all 
parameters in the Heart Rate Variability (HRV) in the stroke 
group were lower than the control group. 
In the control group, BP is inversely proportional to BFV 
(p-value < 0.05 and r ≥ 0.5). In patients with ischemic stroke, 
these changes cannot be done properly, so no difference is 
found between BP and BFV. There is a relationship between 
BP and HRV in the ischemic stroke group, which is 
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associated with high sympathetic nerve activity (p-values < 
0.05 and r > 0.4). The relationship between BFV and HRV 
was also only found in the stroke group (p-value < 0.05 and 
r > 0.4). 
Parameters on HRV that can be used to distinguish stroke 
characteristics are SDRR, CVRR, LF, and VLF which 
describe sympathetic and parasympathetic activities, and 
RMSSD and SD1 which show parasympathetic nerve 
activity. 
Subject quantity in further studies can be added, as well 
as ischemic stroke and control subject groups can be 
categorized based on age and gender. Biosignal used to 
determine the condition of ischemic stroke patients can be 
combined with other biosignals. It is possible to analyze the 
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